Home Archives 2010 April

Monthly Archives: April 2010

The April 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 16, Issue 2


Case studies in innovation: What enables outstanding achievements?PDF
Yali Friedman


Biotechnology marketing: Insider and outsider viewsPDF
Päivi Eriksson, Heidi Rajamäki
The current M&A environment and its strategic implications for emerging biotherapeutics companiesPDF
Mohan Sowlay, Scott Lloyd
Practical approaches to early stage life sciences technology valuationsPDF
Stephen Mayhew
Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regimePDF
Trichi Saukshmya, Archana Chugh
From carbon to carbohydrates: Corporate strategies for biopolymer technology developmentPDF
Avrath Chadha
Biotechnology in the capital region of EuropePDF
Jan Wauters

Legal and Regulatory Updates

Legal and regulatory updatePDF
Gerry Kamstra, John Wilkinson

Conference Report

Funding the dream at the Mid-Atlantic Biotech ConferencePDF
Harley King

Book Reviews

Book Review: Getting to Plan B: Breaking through to a better business modelPDF
Arlen D Meyers
Book Review: Driving innovation – Intellectual property strategies for a dynamic worldPDF
Barry J Marenberg
Book Review: Intellectual property, medicine and health: Current debatesPDF
Stanley P Kowalski
Bird & Bird

As promised, I have posted my observations from the 2009 Kyoto Prize. I had an opportunity to interact with each of the laureates, and focused on the question of how they were able to accomplish their exemplary achievements. It is not enough to simply be brilliant or hard-working — all their peers likely share these characteristics. What are the differentiating factors that enabled their unique achievements?

My observations appear in the latest issue of the Journal of Commercial Biotechnology, and are available for viewing without subscription.

The next DCbiotech meeting will be at the Redwood Restaurant and Bar in Bethesda, MD on April 14th 2010. Redwoods is at 7121 Bethesda Ave, and we’ll be meeting in the bar area from 6-8pm. To facilitate finding the group, you may want to check out my photo on the about page.

Also, we will have a special guest. John Avellanet, frequent BiotechBlog contributor and author of the upcoming book Get to Market Now! will be in attendance. A limited number of books will be available for signing and sale.

Drug Patent Expirations in April 2010

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent Number Patent Expiration
HYZAARMerckhydrochlorothiazide; losartan potassium5,153,197*PEDApr 6, 2010
IPLEXInsmedmecasermin rinfabate recombinant5,200,509Apr 6, 2010
COZAARMercklosartan potassium5,153,197*PEDApr 6, 2010
DUODOTEMeridian Medclatropine; pralidoxime chloride5,092,843Apr 12, 2010
EMBEDAAlpharma Kingmorphine sulfate; naltrexone hydrochloride5,202,128Apr 13, 2010
KADIANActavis Elizabethmorphine sulfate5,202,128Apr 13, 2010
MUSEVivusalprostadil5,773,020Apr 25, 2010
FLOMAXBoehringer Ingelheimtamsulosin hydrochloride4,703,063*PEDApr 27, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com